home / stock / clrb / clrb news


CLRB News and Press, Cellectar Biosciences Inc. From 11/01/23

Stock Information

Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com

Menu

CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...

CLRB - Notable earnings before Thursday's open

2023-11-01 11:48:22 ET Major earnings expected before the bell on Thursday include: Barrick Gold ( GOLD ) Moderna ( MRNA ) Palantir Technologies ( PLTR ) Starbucks ( SBUX ) Shopify ( SHOP ) For further details see: Notable earnings before ...

CLRB - Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Strategic collaboration to advance patient care and further define the U.S. treatment landscape First of several planned community-based cancer care network collaborations for Cellectar to facilitate future patient access and clinical success with iopofosine I 131 FLORHAM PARK, N....

CLRB - Cellectar Biosciences to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 2, 2023

FLORHAM PARK, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of targeted drugs for the treatment of cancer, today announced that the company will repor...

CLRB - Cellectar Biosciences Expands Commercialization Leadership Team Ahead of Pivotal Data for Iopofosine I-131 in Waldenstrom's Macroglobulinemia

William Yoon Appointed Vice President, Medical Affairs Aaditya Nanduri Appointed Vice President, Business Strategy and Analytics FLORHAM PARK, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focuse...

CLRB - Cellectar Biosciences files to sell 34.5M shares for holders

2023-10-05 16:56:44 ET More on Cellectar Biosciences Seeking Alpha’s Quant Rating on Cellectar Biosciences Historical earnings data for Cellectar Biosciences Financial information for Cellectar Biosciences For further details see: Cellectar Bioscie...

CLRB - Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants

FLORHAM PARK, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced significant advancements to ...

CLRB - Cellectar Biosciences Receives European Medicines Agency Priority Medicines (PRIME) Designation for Iopofosine for Waldenstrom's Macroglobulinemia

FLORHAM PARK, N.J., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that the European Medicines...

CLRB - Cellectar Biosciences Announces Closing of up to Approximately $103 Million Private Placement Financing

FLORHAM PARK, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that it has closed on ...

CLRB - CLRB, VERB and LGHL among pre-market losers

2023-09-06 08:31:02 ET Verb Technology Company ( VERB ) -27% . Digital Brands Group ( DBGI ) -14% . GD Culture Group Limited ( GDC ) -12% . EZGO Technologies ( EZGO ) -10% . Photronics ( PLAB ) -9% after Q3 earning release . ...

CLRB - CGC, VNDA and TSE among mid-day movers

2023-09-05 13:07:33 ET Gainers: Helius Medical Technologies ( HSDT ) +a55% . Novo Integrated Sciences ( NVOS ) +38% . Shengfeng Development Limited ( SFWL ) +29% . Cibus ( CBUS ) +28% . Cellectar Biosciences ( CLRB ) +28% . C...

Previous 10 Next 10